ReviewCurrent opinion in lipidology2026
Genetic determinants of plasma lipids in Greenlanders.
Review in Current opinion in lipidology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewGreenlanders differ from other populations in terms of traditional lifestyle and genetic architecture. This might have a great impact on lipid levels in the population and the spectrum of genetic variants associated with lipid traits. Here, we review recent advances in lipid genetics in Greenlanders and highlight the potential of moving from single lipid trait analyses to more comprehensive lipidomic profiling. RECENT
findingsGenetic association studies in the Greenlandic population have identified variants, including PCSK9 (rs12117661), LDLR (rs730882082), and SI (rs781470490), associated with large effects on triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol, and total cholesterol (TC) levels, as well as altered risk of cardiovascular disease (CVD). These variants are common in the Greenlandic population and explain more lipid variation than variants observed in Europeans. Accordingly, European-derived polygenic scores (PGSs) underperform in Greenlanders, but including the Greenlandic variants increases the performance of lipid PGSs. Lipidomic profiling has the potential to reveal strong cardiometabolic-risk signatures. SUMMARY: The Greenlandic population harbors high-impact variants in PCSK9 , LDLR , and SI, particularly affecting the levels of TG, LDL-C, and TC. Obtaining information on these variants could facilitate earlier detection and potentially prevention of CVD, and advance precision medicine for Greenlanders.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.